News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Alliances
Zogenix, Inc. (ZGNX) And Purdue Pharma L.P. Exchange Waivers Of Regulatory Exclusivity For Extended-Release Hydrocodone Products 10/31/2014
Medidata Solutions, Inc. Selected By ASLAN Pharmaceuticals As Enterprise-Wide Technology Platform For Enhancing Clinical Development 10/31/2014
MediGene AG (MDGEF.PK)'s Licensee Enters Promotion Agreement To Expand Veregen® Product Sales In The United States 10/30/2014
Chugai Pharmaceutical Co., Ltd. (Japan) Licenses ISPRI/Optimatrix Platform From EpiVax, Inc. For De-Risking Biologics 10/30/2014
Medivir AB (MVRBF) And County Councils Conclude Agreement On Olysio®-Based Treatment For Hepatitis C 10/30/2014
Transgenomic, Inc. (TBIO) And University of Melbourne Collaborate To Further Validate Ability Of Multiplexed ICE COLD-PCRTM To Enable Personalized Cancer Treatment 10/30/2014
Bristol-Myers Squibb Company (BMY) And Lonza Group Ltd. (LZAGY.PK) Expand Manufacturing Agreement 10/30/2014
Eli Lilly (LLY), Boehringer Mannheim Corporation Revise Terms Of Diabetes Drugs Alliance 10/29/2014
Celerion Completes Recapitalization Through Investment By MTS Capital Health Partners 10/29/2014
Clean TeQ Holdings Limited (ASX:CLQ) Teams Up With Queensland University of Technology's Institute For Future Environments 10/29/2014
Xencor Regains All Rights From Amgen (AMGN) To Rare AutoImmune Disease Drug, Dumps Arthritis Hopes 10/29/2014
Imprimis Pharmaceuticals (immy) Enters Into License Agreement For Patented Urology Formulation 10/29/2014
Polyplus Transfection And Blue Sky Bioservices Sign A Research And Commercial License Agreement For Use Of PEI-Based Transfection Technologies 10/29/2014
Bristol-Myers Squibb Company (BMY) Forges $475 Million Pact For Rights To f-Star's Cancer Drug 10/28/2014
Amgen (AMGN), Ono Pharmaceutical Company, Ltd., Sanofi (SAN.PA) Team Up With Academia On Proteins Project 10/28/2014
Amunix, Inc. And PolyPeptide Laboratories Inc. Enter Into Partnership To Produce XTEN™ Peptide Conjugates For Evaluation By Third Parties For Pharmaceutical Therapeutics 10/28/2014
N-of-One Selected By Intermountain Healthcare To Provide Deep Clinical Interpretation For Cancer Genomics 10/28/2014
Janssen Signs Translational Medicine MOU With Shanghai Ruijin Hospital 10/28/2014
Iroko Pharmaceuticals Announces New Strategic Agreement To Commercialize ZORVOLEX® In Australia And New Zealand 10/28/2014
Molecular Devices, Inc. (MDCC) Partners With Roche to Develop Custom Ruthenium Nano-TRF® Detection Platform 10/28/2014
Enerkem Announces New Project Partnership In China 10/28/2014
BioDelivery Sciences International (BDSI)To Develop A Long-Acting Injectable Depot Formulation Of Buprenorphine With Evonik Industries For Use In Opioid Dependence And Pain 10/28/2014
Oncolytics Biotech Inc. (ONC.TO) Announces Entry Into $20 Million "At-The-Market" Equity Distribution Agreement With Canaccord Genuity Inc. 10/28/2014
Nagoya University’s ITbM, Japan, Licenses Cresset’s Computational Chemistry Software To Accelerate Their Research 10/28/2014
KineMed, Inc. And US Army Announce Collaboration To Measure Muscle Function And Response During Military Operations 10/28/2014
Wolters Kluwer Health Partners With Philips Clinical Informatics To Revolutionize Access To Clinical Decision Support In Brazil 10/28/2014
Triphase Accelerator Announces Expanded Collaboration With Celgene (CELG) 10/28/2014
Triphase Accelerator Accelerator Corporation Announces New Collaboration With Celgene (CELG) 10/28/2014
PharmAbcine Announces Global Licensing Deal With Triphase Accelerator For VEGFR-2/TIE 2 Bi-Specific Antibody 10/28/2014
ProtoKinetix Inc. (PKTX.OB) Announces Termination Of Intrepid Agreement 10/28/2014
Pain Therapeutics (PTIE) Tanks As Pfizer (PFE) Walks Away From Remoxy® Deal 10/27/2014
Cellular Dynamics International Awarded $1.2 Million National Eye Institute Contract For Developing Patient-Derived Stem Cells In Gear-Up For Age-Related Macular Degeneration Trial 10/27/2014
Calchan And Galapagos NV (GLPG.BR) Collaborate On Osteoarthritis Pain Research 10/27/2014
PlasmaTech Biopharmaceuticals Signs Expanded MuGard Licensing Agreement With Norgine For Australia And New Zealand Territories 10/27/2014
Alexza Pharmaceuticals, Inc. (ALXA) And Ferrer Internacional Expand ADASUVE® Partnership 10/27/2014
Clontech Laboratories, Inc. Licenses CRISPR/Cas9 Technology From The Broad Institute 10/27/2014
pSivida Corp (PSDV) Pockets $25 Million Milestone Payment 10/27/2014
Mersana Therapeutics, Inc. And Takeda (TKPYY) Enter Commercial License Agreement For Novel Fleximer® Antibody-Drug Conjugate 10/27/2014
Oxford University And Pronova Partner To Bring First Proton Research Center To The United Kingdom 10/27/2014
Mersana Therapeutics, Inc. And Takeda Pharmaceutical Co. Ltd. (TKPYY) Enter Commercial License Agreement For Novel Fleximer® Antibody-Drug Conjugate 10/27/2014
The Dow Chemical Company (DOW) Licenses Simulations Plus (SLP) Software To Assist With Toxicology And Environmental Research 10/27/2014
NanoViricides, Inc. (NNVC.PK) Signs CRADA For Material Transfer With USAMRIID For Evaluating Its Anti-Ebola Drug Candidates 10/27/2014
Vernalis PLC (VNLPY.PK) Announces CTI BioPharma Becomes Worldwide Licensee For Tosedostat 10/27/2014
Bioheart, Inc. Completes Financing With Magna 10/27/2014
Amunix, Inc. Signs A Services And Supply Agreement With The University Of Nebraska-Lincoln To Produce GMP-Grade XTEN™ For Pharmaceutical Therapeutics 10/27/2014
Genmab A/S (GEN.CO) Banks $10 Million Milestone Payment From Janssen Biotech Inc. (JNJ) 10/24/2014
National Stem Cell Foundation Release: Stem Cell And Orthopaedic Foundations Partner On Stem Cell Research 10/24/2014
Medivation, Inc. (MDVN) Licenses Clinical Stage Anti-PD-1 Immune Modulatory Monoclonal Antibody From CureTech Ltd. For Potential Applications In Oncology 10/24/2014
Stellar Biotechnologies, Inc. And Biovest International, Inc. Sign KLH Supply Agreement For BiovaxID Immunotherapy For Follicular Non-Hodgkin's Lymphoma 10/24/2014
Five Prime Therapeutics, Inc. (FPRX) Snags An Expanded Deal Worth $196.3 Million With GlaxoSmithKline (GSK) 10/24/2014
Eli Lilly (LLY) Adds $375 Million To Zymeworks Partnership 10/23/2014
Covidien (COV) Joins Forces With American Lung Association To Help Women Understand Their Increased Risk Of Lung Cancer 10/23/2014
SSF's Sutro Biopharma Forges $1 Billion+ And Option To Buy Pact With Celgene (CELG) 10/23/2014
MorphoSys AG To Receive Milestone Payment For Guselkumab Phase 3 Program 10/23/2014
Tufts Medical Center And Lowell General Hospital Finalize Agreement Forming New Health System 10/23/2014
Neovacs SA And Kepler Cheuvreux Sign A Financing Project 10/23/2014
Inocucor Technologies And McGill University To Collaborate On Bio-Stimulants For Large-Scale Agriculture 10/23/2014
Lucideon (Formerly Known As CERAM) To Jointly Run Biodensol Project 10/23/2014
R-Tech Ueno: Sucampo Pharmaceuticals, Inc. (SCMP) And Takeda (TKPYY) Enter Into Global Licensing Agreement For AMITIZA® (Lubiprostone) 10/23/2014
CRF Health Joins Industry-Leading Perceptive® Partner Program 10/23/2014
GlaxoSmithKline (GSK), Johnson & Johnson (JNJ) Join Forces To Make Millions Of Ebola Vaccine Doses 10/22/2014
Lexicon Pharmaceuticals, Inc. (LXRX), Ipsen (IPN.PA) Strike Licensing Deal Worth $145 Million 10/22/2014
Sucampo Pharmaceuticals, Inc. (SCMP), Takeda (TKPYY) Forge $55 Million Deal For Amitiza® 10/22/2014
Foundation Medicine, Inc. (FMI) And WuXi PharmaTech Co., Ltd. Announce Strategic Collaboration To Offer Best-In-Class Comprehensive Genomic Profiling In China 10/22/2014
Profectus BioSciences, Inc. Receives $8.6 Million HHS Contract To Accelerate Ebola Vaccine Into Human Clinical Studies 10/22/2014
Daxor Corporation (DXR) Announces Research Agreement With Virginia Commonwealth University On Burn Patients 10/22/2014
Terumo BCT And OneBlood Partner In A Treatment Use Program Of An Investigational Device To Help Improve Blood Supply Safety 10/22/2014
iBio, Inc. (IBIO) Expands Exclusive Product Collaboration With Novici Biotech 10/22/2014
Quest PharmaTech Inc. To Market And Distribute Premium Anti-Wrinkle Skin Care Product, Bellus Skin™; Dr. Jacqueline Shan, Creator Of COLD FX®, To Assist 10/22/2014
Xbrane Bioscience Signs Major Biosimilar Agreement With Global Indian Pharmaceutical Company 10/22/2014
PureMHC Release: Biotech Companies To Co-Discover And Co-Develop Antibodies Targeting Novel Phosphopeptide Tumor Targets 10/22/2014
UCB Group (UCBJF.PK) Deploys IMS Health Nexxus Suite And Intelligent Cloud To Drive Commercial Productivity, Accelerate Time To Insight 10/22/2014
Center For Connected Health And Daiichi Sankyo, Inc. (4568.t) Sign Agreement To Co-Develop A Mobile App To Support Patients With Atrial Fibrillation 10/22/2014
Masters Speciality Pharma Signs Exclusivity Agreement With Speciality European Pharma For The Exclusive Distribution Of Mitocin®/Mitem® 20mg (mitomycin) 10/22/2014
Opexa Therapeutics (OPXA) Supports National Multiple Sclerosis Society And Walk MS 10/22/2014
Enanta Pharmaceuticals, Inc. Rejects HCV Drug Co-Development Option With AbbVie (ABBV) 10/21/2014
Rho Awarded New Federal Contract From National Institute Of Dental And Craniofacial Research 10/21/2014
Iroko Pharmaceuticals Signs New Strategic Agreement With Landsteiner Scientific To Bring ZORVOLEX® To Mexico 10/21/2014
MACROGEN Selects GenoLogics Life Sciences Software Inc.’s Clarity LIMS To Strengthen X-Genome And Clinical Sequencing Services 10/21/2014
Sysfera And Kitware Partner To Integrate HPC Technologies For Improved Scientific Data Analysis 10/21/2014
Immunotech Laboratories Enters Into Agreement To Market Potential Ebola Virus Disease (“EVD”) Treatment And Implement Strategy For Company's ITV-1 Infectious Diseases Treatment In Africa 10/21/2014
Oncolytics Biotech Inc. (ONC.TO) Announces Amendment To Common Share Purchase Agreement With Lincoln Park Capital Fund, LLC 10/21/2014
Inovio Pharmaceuticals (INO), MedImmune (AZN) And The University of Pennsylvania Partner To Combat Influenza And Antibiotic Resistant Bacteria 10/21/2014
Synergy Research Group Joins Clinovo’s CRO Partnership Program, Extending Its Open Source EDC System ClinCapture To Russia And The Eastern Europe Region 10/21/2014
Addex Therapeutics (ADXN.SW) And The Charcot-Marie-Tooth Association Enter Collaboration To Advance ADX71441 In Charcot-Marie-Tooth 1A Disorder 10/21/2014
Harvard University And EPFL Join Forces In Research Projects To Tackle Blindness Andd Deafness Through Neuroengineering 10/21/2014
Celltex Therapeutics Corporation Announces ‘Joint’ Partnership With Arthritis Foundation South Central Region 10/21/2014
Inovio Pharmaceuticals (INO), MedImmune (AZN) And University of Pennsylvania Partner To Combat Influenza And Antibiotic Resistant Bacteria 10/21/2014
SomaLogic, Inc. Announces Extension Of Multi-Year Collaboration Agreement 10/21/2014
Theranostics Health And Grace Bio-Labs Strike Licensing Agreement For Novel TheraLin® Tissue Fixative 10/21/2014
Genentech (RHHBY), NewLink Genetics Strike $1 Billion+ Cancer Deal 10/21/2014
Amgen (AMGN) Will Assign 12 To 14 Staff Members To Look Into An Alternative Production Method For Mapp Biopharmaceutical's ZMapp 10/20/2014
TesoRx, Aspen Group Ink $95 Million Pact 10/20/2014
Sirona Biochem Announces Research Collaboration With Aegilops Applications 10/20/2014
Hemispherx Biopharma (HEB) Announces Strategic Relationship With Squire Patton Boggs, Washington, DC As Governmental Counsel In Fight Against Ebola 10/20/2014
Forendo Pharma Licenses U.S. Fispemifene Rights To Apricus Biosciences (APRI) In Deal Worth $305 Million 10/20/2014
Apricus Biosciences (APRI) Expands Development Pipeline With The In-Licensing Of U.S. Rights For Fispemifene, A Phase 2b Ready Asset, From Forendo Pharma Targeting Urological Conditions In Men 10/20/2014
Neptune Technologies & Bioressources Inc. And BlueOcean Sign Licensing Agreement 10/20/2014
Nuvilex (NVLX) Contracts With University Of Veterinary Medicine In Vienna To Conduct Preclinical Studies On The Use Of Cell-In-A Box® To Develop Diabetes Treatment 10/20/2014
Humacyte, Inc. Selected To Join U.S. Secretary Of Commerce On Trade Mission To Asia 10/20/2014
New England Biolabs, Inc. And Directed Genomics Partner To Develop Novel Target Enrichment Technologies For Next Generation Sequencing 10/20/2014
The Hereditary Neuropathy Foundation And BioPontis Alliance For Rare Disease Partner To Develop Treatments For Charcot-Marie-Tooth 10/20/2014
Affymetrix (Santa Clara, California) (AFFX) Exclusively Licenses Technology From Peptide Groove LLP For HLA Typing From Genotyping Data 10/20/2014
Clean TeQ Holdings Limited (ASX:CLQ) And SIDRI Sign Heads Of Agreement 10/20/2014
Calixar And Aston University Together In Collaborative Research To Tackle Multidrug Resistance Targets 10/20/2014
Berkeley's Aduro Biotech Strikes $817 Million Lung Cancer Pact With Janssen Biotech Inc. (JNJ) 10/17/2014
Astellas Pharma Inc. (ALPMY), CoMentis, Inc. Terminate Alzheimer's Agreement 10/17/2014
Portola Pharmaceuticals, Inc. Announces Commercial Supply Agreement For Andexanet Alfa With Lonza Inc. 10/17/2014
Novadaq Corp. Appoints Kirloskar Technologies As Its Exclusive Distributor In India 10/17/2014
Osiris Therapeutics, Inc. (OSIR) And Arthrex, Inc. Announce An Exclusive Partnership For The Commercialization And Development Of Cartiform® 10/17/2014
Sihuan Pharmaceutical Announces Second Anti-Virus Partnership With AMMS 10/17/2014
AstraZeneca PLC (AZN) Strengthens Partnership With The University of Cambridge 10/16/2014
Sanofi Pasteur (SASY.PA) And Immune Design Corporation (IMDZ) Enter Broad Collaboration For The Development Of A Herpes Simplex Virus Therapy 10/16/2014
Nuvilex (NVLX) Secures Worldwide License For Insulin-Producing Cells From University of Technology Sydney, For Use In Developing Diabetes Treatment 10/16/2014
Moderna Therapeutics, Inc. To Collaborate With Karolinska Institute And Karolinska University Hospital On Discovery Of New Messenger RNA Therapeutics™ 10/16/2014
Cardiorentis AG And Roche (RHHBY) Announce Collaboration To Establish Therapeutic Impact Of Ularitide 10/16/2014
Batu Biologics Awarded Exclusive License From University of California, San Diego (UCSD) for Drug That Stimulates Immune System To Kill Cancer 10/16/2014
DNAnexus, Inc. Powers Novel Genomic Collaborations Between Regeneron Genetics Center And Leading Healthcare Institutions 10/16/2014
Tocris Bioscience And The Structural Genomics Consortium Sign Agreement For the Worldwide Distribution Of Novel Epigenetic Chemical Probes 10/16/2014
Pharmacyclics, Inc. (PCYC) Enters Into Agreement With Roche (RHHBY) To Evaluate IMBRUVICA® And GAZYVA® In Lymphoma And Leukemia 10/16/2014
Orexigen Therapeutics, Inc. (OREX) Pockets $100 Million Milestone Payment From Takeda Pharmaceutical Co. Ltd. (TKPYY) 10/15/2014
Boehringer Ingelheim Corporation And Americares Partner To Expand Product Donations Program Globally 10/15/2014
Selecta Biosciences, Inc., Juvenile Diabetes Research Foundation And Sanofi (SAN.PA) Extend Collaboration To Develop A Synthetic Vaccine Particle Immunotherapy For Type 1 Diabetes 10/15/2014
Discovery Laboratories (DSCO) Announces Strategic Collaboration With Battelle For AEROSURF® Program 10/15/2014
Bioheart, Inc. Announces Partnership In Colombia 10/15/2014
Deinove Teams Up With MBI, Pioneer Of Afex Technology, To Evaluate Its Process On Industrial Biomass 10/15/2014
NeuroSigma, Inc. And The U.S. Veterans Administration (VA) Enter Into Cooperative Research And Development Agreement (CRADA) 10/15/2014
Auspherix And Domainex Announce Collaboration To Develop New Drugs To Treat Antibiotic-Resistant Bacterial Infections 10/15/2014
Embattled Wilex AG (WL6.DE) Sells Unnamed Tumor Drug To Roche (RHHBY) For $65.8M 10/14/2014
Retrophin (RTRX) Announces Divestment Of Non-Core Assets To Turing Pharmaceuticals 10/14/2014
Advanced Biological Laboratories SA (ABL), University of Hong Kong, And The Hong Kong Polytechnic University Decide To Join Forces To Develop A Deep-Sequencing Tuberculosis Solution 10/14/2014
INC Research, Inc. Signs Agreement To Perform FDA Due Diligence Audit Of Regulatory Documents For Provectus Biopharmaceuticals Inc. 10/14/2014
Imaxio Signs An Option For A License Agreement With The German Cancer Research Center (DKFZ) 10/14/2014
BioSilta And Sigma-Aldrich Corporation (SIAL) Sign Global Distribution Agreement 10/14/2014
New Oncology And Gustave Roussy Announce Collaboration On Genetic Testing 10/14/2014
SELLAS Life Sciences Group Selects PPD, Inc. (PPDI) As Its Strategic CRO Partner To Advance Zolpidem And WT1 Cancer Vaccine 10/14/2014
The National Parkinson Foundation Partners With The International Parkinson And Movement Disorder Society To Deliver Health Professional Course 10/14/2014
Prophylix Pharma Signs Manufacturing Agreement With Emergent BioSolutions (EBS) 10/14/2014
Seahorse Bioscience And University of Alabama at Birmingham Partner To Advance Validation Of Bioenergetic Health Index For Personalized Medicine 10/14/2014
Exostar And BT Upgrade Relationship With New Alliance Agreement 10/14/2014
Cesca Therapeutics Announces Agreement With New York Upstate Cord Blood Bank 10/13/2014
Aratana Therapeutics (PETX) And Atopix Complete Global Licensing Agreement For Development And Commercialization Of Novel Atopic Dermatitis Program 10/13/2014
Biocept, Inc. (BIOC) And Rosetta Genomics Ltd. (ROSG) Collaborate To Evaluate Micrornas From Circulating Tumor Cells 10/13/2014
Rich Pharmaceuticals Announces Assignment Agreement Acquiring Complete Ownership, Development And Commercialization Rights For Indication, Patents And Intellectual Property Related To The Treatment Of Hodgkin's Lymphoma 10/13/2014
Veristat, Inc. And Molecular Templates Inc. Enter Into Preferred Provider Agreement For Refractory Non-Hodgkin’s B-Cell Lymphoma trial 10/13/2014
Sihuan Pharma Buys Rights To Ebola Drug From China's AMMS 10/13/2014
Week In Review: Lee's Pharmaceutical Pays $50 Million For Novel Cancer Drug From Sorrento Therapeutics, Inc. 10/13/2014
Hikma Pharmaceuticals Enters Partnership With Eisai Company, Ltd. (ESALY.PK) For Distribution Of First-In-Class Epilepsy Treatment Fycompa® In Middle East 10/13/2014
Nanobiotix Reaches The Second Milestone Payment Of BPIFrance Dedicated To NBTXR3 Development In Liver Cancers 10/13/2014
Bristol-Myers Squibb Company (BMY), Pharmacyclics, Inc. (PCYC), And Janssen Research & Development Announce Clinical Collaboration To Evaluate OPDIVO® (Nivolumab) And IMBRUVICA®(Ibrutinib) In Non-Hodgkin Lymphoma 10/13/2014
Pharming Group (PHGUF.PK) And Swedish Orphan Biovitrum Amend And Extend Ruconest Distribution Agreement 10/13/2014
Onxeo Reaches Second Milestone Of BPIFrance Grant Dedicated To Livatag® Development As Part Of National Institute for Clinical Excellence (NICE) Consortium 10/13/2014
MRC Technology And Proximagen Group plc. Collaborate To Develop Novel Therapeutics For Inflammatory And Autoimmune Disease 10/13/2014
Bacterial Robotics Announces Strategic Alliance With Bacmine SL And Formation Of Microbial Robotics 10/10/2014
AstraZeneca PLC (AZN) Completely Cuts Ties With Targacept, Inc. (TRGT) 10/10/2014
We've Secured Third Biosimilar License: Stada CEO 10/10/2014
Vernalis Licenses V2006 To Redoxtherapies Inc For Use In Immuno-Oncology 10/10/2014
ContraFect Corporation (CFRXU) And China's IVDC Collaborate On Universal Flu Treatment 10/10/2014
Oxford BioMedica PLC (OXB.L) Inks Transformational $90 Million Deal With Novartis AG (NVS) 10/10/2014
Isis Pharmaceuticals, Inc. (ISIS) Pockets $18 Million From GlaxoSmithKline (GSK) 10/9/2014
Capricor Therapeutics, Inc. Announces Plans To Pursue A Cenderitide Clinical Program And Enters Into Research Support Agreement With Insulet Corporation (PODD) 10/9/2014
A*STAR’s Simtech Joins Hands With 8 Companies To Overcome Counting, Tracking And Supply Chain Woes 10/9/2014
International Medica Foundation Provides A Global Sublicense For The First Rotavirus Vaccine Intended For Newborns 10/9/2014
Immunotech Laboratories Enters Into Negotiations With Uldic Investment Pvt. Ltd. For Market Development 10/9/2014
ContraFect Corporation (CFRXU) And National Institute For Viral Disease Control And Prevention, China CDC Sign Agreement To Collaborate On Universal Influenza Treatment 10/9/2014
Procter & Gamble (PG) Release: Pepto-Bismol Partners With Six Flags To Bring Fright Fest® Guests More Thrills 10/9/2014
Tekmira (TKMR) Working Hand In Hand With WHO On Ebola Drug, Says CEO 10/8/2014
Med Fusion And GenomOncology Partner To Match Drug And Clinical Trial Options To Patient Tumors 10/8/2014
PharmaEngine, Inc. Will Join Nanobiotix' Pivotal Trial For NBTXR3 In Soft Tissue Sarcoma To Accelerate Its Development In Asia-Pacific 10/8/2014
Pfizer (PFE) And Breast Cancer Leaders Join Together To Increase Understanding And Dispel Myths About Metastatic Breast Cancer 10/8/2014
Cardio3 BioSciences Awarded Preferred Access Rights To Mayo Clinic Center For Regenerative Medicine Portfolio 10/8/2014
Dilafor Signs Supply And Partnership Agreement With OPOCRIN S.p.A 10/8/2014
Ubiquigent And University of Dundee Announce Collaboration To Develop Novel Ubiquitin System Targeted Compound Libraries 10/8/2014
BASF And Colorcon, Inc. Cooperate On Kollicoat® IR For Ready-To-Use Pharmaceutical Coating Solutions 10/8/2014
Merck Serono, Institute Of Cancer Research, Wellcome Trust To Co-Develop Cancer Drugs 10/7/2014
Hyperion Therapeutics (HPTX), Clal Biotechnology Industries Resolve Dispute Over $570 Million Biotech Problem 10/7/2014
Progenics Pharmaceuticals, Inc. (PGNX) Pockets A $40 Million Milestone Payment From Salix Pharmaceuticals, Ltd. (SLXP) 10/7/2014
The Texas A&M University System And XOMA (US) LLC (XOMA) License Innovative Manufacturing Technology 10/7/2014
ICF International Wins $100 Million Blanket Purchase Agreement With National Institutes of Health (NIH) 10/7/2014
New England Biolabs, Inc. Announces Supply Agreement With TriLink BioTechnologies 10/7/2014
Second Genome And Mayo Clinic Enter Collaboration To Develop Microbiome Therapeutics In Multiple Diseases 10/7/2014
Arcadia Biosciences, Inc. And ArborGen To Develop Drought-Tolerant And Nitrogen-Efficient Eucalyptus Trees 10/7/2014
Charles River Laboratories (Massachusetts)’s Early Drug Discovery Collaboration With AstraZeneca PLC (AZN) Delivers Respiratory Candidate Drug 10/7/2014
Bukwang Pharm. Ind. Co., Ltd. Receives First Performance Milestone Payment From Bukwang Pharm. Ind. Co., Ltd. 10/7/2014
Novartis AG (NVS) Teams Up With Bristol-Myers Squibb Company (BMY) To Test Lung Cancer Drugs 10/6/2014
The Reason Why Takeda Pharmaceutical Co. Ltd. (TKPYY) May Pay MacroGenics, Inc. (MGNX) Up To $1.6 Billion For Four Molecules That Don't Yet Exist 10/6/2014
Alliqua Biomedical (ALQA) Announces Expansion To Its Exclusive Licensing Agreement With Celgene Cellular Therapeutics 10/6/2014
Unilife Corporation (UNIS), Sanofi (SAN.PA) Strike $50 Million Wearable Injectors Pact 10/6/2014
Immucor Announces NGS Collaboration With Sirona Genomics 10/6/2014
Collaboration With Dr. Stephen Waxman Of Yale University To Evaluate Pharmacology Of Nav1.7 Mutations In Chronic Pain Disorders 10/6/2014
Horizon Discovery Group Signs Co-Exclusive Commercial Agreement With Haplogen Genomics 10/6/2014
Bristol-Myers Squibb Company (BMY) And MD Anderson Cancer Center Announce Novel Research Collaboration In Immuno-Oncology Focused On Leukemia And Hematologic Malignancies 10/6/2014
West Pharmaceutical Services And HealthPrize Technologies Join Forces On Connected Health 10/6/2014
Society For Clinical Research Sites Welcomes New Global Impact Partner 10/6/2014
ARTES Biotechnology, instrAction and Q-Biologicals Join Forces for Veterinary Vaccine Development 10/6/2014
Lockheed Martin Corporation And Yissum Ltd. Sign Long Term Research Collaboration Agreement 10/6/2014
Perosphere Inc. And Daiichi Sankyo, Inc. (4568.t) Enter Into A Clinical Trial Collaboration Agreement For Phase 3 Studies Of PER977 To Investigate Reversal Of The Anticoagulant Activity Of The Investigational Factor Xa-Inhibitor Edoxaban 10/6/2014
Pharmaceutical Services Provider Biosolutia Turns To 8x8 To Ensure Uptime, Security And Customer Engagement Success For Cloud Contact Center 10/6/2014
Islet Sciences Announces Exclusive Licensing Agreement Between BHV Pharma, Inc. And Libbs Farmaceutica To Develop And Commercialize SGLT2 Inhibitor Remogliflozin Etabonate 10/6/2014
India Brand Equity Foundation (IBEF), Release: Government Of India And Pharma Industry Jointly Form The India – Responsible Healthcare Trust 10/6/2014



//-->